NATF President’s Perspective & Welcome
Samuel Z. Goldhaber, MD, Professor of Medicine at Harvard Medical School, is Section Head of Vascular Medicine in the Cardiovascular Medicine Division at Brigham and Women’s Hospital.

Riding the Wave of mRNA Vaccine Technology: Applications in Cardiovascular Medicine
Kathryn E. Stephenson, MD, MPH, Assistant Professor of Medicine, Harvard Medical School
Staff Physician, Division of Infectious Diseases and Principal Investigator, Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center

Thromboinflammation in COVID-19: Lessons in Thrombosis for a Post-Pandemic World
Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School; Cardiovascular Specialist, Brigham and Women’s Hospital

Long COVID Syndrome: A Pandemic After the Pandemic? Kristin Englund, MD, MLS, Assistant Professor, Cleveland Clinic Lerner College of Medicine of CWRU; Staff Physician, Cleveland Clinic

Missed and Delayed Cardiovascular Care during the COVID-19 Pandemic: Consequences for Population Health 
Karen Joynt Maddox, MD, MPH, Associate Professor, Washington University School of Medicine; Cardiologist, Barnes-Jewish Hospital

Healthcare Disparities Exposed: How COVID-19 Showed Us That We Need to Do Better 
Cassandra Pierre, MD, MSc, MPH, Assistant Professor of Medicine, Boston University School of Medicine; Associate Hospital Epidemiologist, Boston Medical Center

Recorded Q&A and Panel Discussion
Moderator: Gregory Piazza, MD, MS, Cardiovascular Medicine Specialist, Brigham and Women’s Hospital; Associate Professor of Medicine, Harvard Medical School

By the end of the session the participant will be able to:

• Recall how mRNA technology used to develop vaccines for COVID-19 can be leveraged in cardiovascular medicine
• Explain how the link between inflammation and thrombosis that has characterized COVID-19 has implications for other aspects of medicine
• Describe long COVID syndrome and how medicine will handle this complication of COVID-19
• Summarize trends in cardiovascular care utilization during the COVID-19 pandemic and implications for future burden of disease and formulate a patient care plan based on that information
• Recognize healthcare disparities exposed by COVID-19 and how medicine needs to make changes for the health of all our communities

ACCME Activity #202288537

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

Kathryn E. Stephenson, MD, MPH, Assistant Professor of Medicine, Harvard Medical School
Staff Physician, Division of Infectious Diseases and Principal, Investigator, Center for Virology and Vaccine Research Beth Israel, Deaconess Medical Center, is a clinical investigator for vaccine and immunotherapy trials funded by Regeneron, Gilead, and Johnson & Johnson.

Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School, Cardiovascular Specialist, Brigham and Women’s Hospital, reports the following relationships with commercial entities:

• Unpaid Consultant and/or unpaid steering or executive committee of clinical trials: Amgen, Esperion, Gnentech, Kowa, Merck, Novartis, Pfizer, Sanofi-Aventis-Regeneron.
• Scientific Advisory Board: Amgen, Beren, Caristo, Cartesian, CSL Behring, DalCor, Dewpoint, Kancera, Medimmune,Novartis, NovoNordisk, Olatec, PlaqueTec, Xbiotech. Board : Xbiotech.

Karen Joynt Maddox, MD, MPH, Associate Professor, Washington University School of Medicine, Cardiologist, Barnes-Jewish Hospital, was a member of a health policy advisory committee for Centene Corp.

Course planner: Gregory Piazza, MD, MS Director, Vascular Medicine Section Brigham and Women's Hospital Associate Professor of Medicine Cardiovascular Medicine has received research grants from Alexion, Amgen, Bayer, Bristol-Myers Squibb, Pfizer, BSC, and Janssen.

Moderator: Samuel Z. Goldhaber, MD, President, NATF has received research grants from Alexion, Amgen, Bayer, Bristol-Myers Squibb, Pfizer, BSC, and Janssen and has been a paid consultant of Agile, Bayer, and Pfizer.

Individuals with no conflicts of interest to disclose:

• Faculty member: Kristin Englund, MD, MLS, Assistant Professor, Cleveland Clinic Lerner College of Medicine of CWRU, Staff Physician, Cleveland Clinic
• Faculty member: Cassandra Pierre, MD, MSc, Assistant Professor of Medicine, Boston University School of Medicine, Associate Hospital Epidemiologist, Boston Medical Center
• Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

*Required to view Printable PDF Version